Continuous administration of pharmaceutical compositions for the treatment of neurodegenerative diseases
WO2017039525A1
Method of treating a dopamine related disorder in a subject by administering levodopa, in combination with a dopamine decarboxylase inhibitor and a catechol-o-methyltransferase inhibitor
CA2959307A1
Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a comt inhibitor and method of administration thereof
SE1451034A1
Pharmaceutical compositions comprising levodopa, carbidopa and a comt inhibitor and method of administration thereof
